Bioprinting of Cartilage and Skin Tissue Analogs Utilizing a Novel Passive Mixing Unit Technique for Bioink Precellularization
January 3rd, 2018
14.4K views
Cartilage and skin analogs were bioprinted using a nanocellulose-alginate based bioink. The bioinks were cellularized prior to printing via a single step passive mixing unit. The constructs were demonstrated to be uniformly cellularized, have high viability, and exhibit favorable markers of differentiation.
Overview
This study presents a method for pre-cellularizing bioinks using a passive mixing unit, ensuring high cell viability and uniform cellularization in bioprinted constructs. The technique utilizes a nanocellulose-alginate based bioink and demonstrates effective blending of cell suspensions with minimal handling.
Key Study Components
Area of Science
- Bioprinting
- Tissue Engineering
- Cell Viability
Background
- Bioprinting requires precise mixing of bioinks and cell suspensions.
- Maintaining cell viability during the mixing process is crucial.
- Passive mixing units can enhance reproducibility and minimize sample loss.
- Visual demonstrations are essential to avoid improper mixing.
Purpose of Study
- To develop a reproducible method for pre-cellularizing bioinks.
- To streamline the blending process of cell suspensions with bioinks.
- To ensure high viability of cells in bioprinted constructs.
Methods Used
- Preparation of cell suspensions and bioinks in sterile conditions.
- Utilization of a passive mixing unit for blending.
- Bioprinting of constructs with specified dimensions.
- Crosslinking of constructs post-printing for structural integrity.
Main Results
- Constructs were uniformly cellularized with high viability.
- Passive mixing improved cell viability compared to manual mixing.
- Final cell density achieved was nine million cells per milliliter.
- Histological analysis showed production of glycosaminoglycans.
Conclusions
- The passive mixing method is effective for preparing bioinks.
- This technique can enhance the quality of bioprinted tissue constructs.
- Future studies may explore further applications in tissue engineering.
Frequently Asked Questions
What is the main advantage of using a passive mixing unit?
It minimizes handling and risk of sample loss while ensuring effective mixing of bioinks and cell suspensions.
What type of bioink was used in this study?
A nanocellulose-alginate based bioink was utilized for bioprinting.
How was cell viability assessed?
Cell viability was assessed using the trypan blue exclusion method after mixing.
What was the final cell density achieved in the constructs?
The final cell density achieved was nine million cells per milliliter.
What was the purpose of crosslinking the constructs?
Crosslinking was performed to enhance the structural integrity of the bioprinted constructs.
How were the constructs analyzed post-printing?
Constructs were analyzed histologically for glycosaminoglycan production at weeks two and four.
Executive Industry Relevance
Efficient and reproducible bioink pre-cellularization is critical for scalable bioprinting in tissue engineering R&D, where uniform cell distribution directly impacts construct functionality and reduces batch failure risk. The passive mixing unit technique addresses a key bottleneck in early-stage discovery workflows by enabling rapid, gentle blending of high-viscosity bioinks with cell suspensions while maintaining viability. This supports predictive confidence in downstream applications such as assay-ready tissue models and preclinical validation studies by minimizing variability introduced during bioink preparation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of cellular microenvironment effects by ensuring homogeneous cell distribution in bioprinted constructs, reducing noise in phenotypic readouts.
- Operational Value: Streamlines bioink preparation with minimal handling, improving reproducibility across discovery experiments and reducing sample loss during mixing.
Screening & Assay Development
- Scientific Value: Produces uniformly cellularized constructs suitable for high-fidelity screening of biomaterials or bioactive compounds in cartilage and skin tissue models.
- Operational Value: Standardizes bioink preparation, supporting assay reproducibility and scalability for multi-well or high-throughput bioprinting platforms.
Translational & Preclinical Research
- Scientific Value: Generates disease-relevant tissue analogs with deposited ECM markers (e.g., GAGs, collagen I), enabling mechanistic de-risking of therapeutic candidates in physiologically contexted models.
- Operational Value: Supports translational continuity from discovery to preclinical validation by providing standardized, viable tissue constructs for longitudinal culture and histological analysis.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by enabling reliable preparation of cell-laden bioinks for bioprinting, positioning it upstream of construct fabrication and downstream of cell sourcing and expansion, with direct utility in generating screening-ready tissue models.
- Discovery Biology: Supports hypothesis testing in tissue engineering by providing consistent, viable cellularized constructs for evaluating biomaterial-cell interactions and microenvironmental cues.
- Screening: Delivers assay-ready constructs with uniform cell distribution, enabling reliable compound screening and dose-response evaluation in bioprinted cartilage and skin analogs.
- Analytics: Facilitates quantitative histological readouts (e.g., GAG and collagen I deposition) that allow teams to compare construct maturation and ECM production across conditions.
- Translational Research: Connects discovery-stage bioprinting to preclinical validation through stable, long-term culture (up to 4 weeks) and tissue-specific ECM deposition, supporting risk-adjusted advancement decisions.
- Enterprise Reuse: Establishes a reusable, standardized platform for bioink pre-cellularization applicable across multiple tissue types and bioprinting projects, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by reducing mechanistic ambiguity from uneven cell distribution, improving data fidelity in tissue model-based studies.
- Operational Value: Increases standardization and reproducibility of bioink preparation, minimizing variability and sample loss in R&D workflows.
- Strategic Value: Supports better go/no-go decisions by enabling reliable generation of viable tissue constructs, reducing late-stage biological risk in translational programs.
- Portfolio Impact: Enables risk-adjusted prioritization of biomaterial and cell therapy candidates through consistent, high-fidelity preclinical models.
Implementation Considerations
- Requires aseptic technique and familiarity with sterile fluid handling, including syringe preparation and luer lock connections.
- Dependent on access to a dispensing unit capable of synchronized extrusion and a sterile passive mixing unit compatible with dual syringes.
- Necessitates standardization of mixing ratios (e.g., 10:1 bioink to cell suspension) and priming procedures to ensure consistent results across users and batches.
- Requires adaptation of bioink formulation and crosslinking strategy (e.g., calcium chloride for nanocellulose-alginate) based on target tissue mechanics and gelation kinetics.
- Practical limitations include the need for visual verification of mixing completeness and potential constraints in scaling to very high cell densities without affecting bioink rheology.
Biopharma FAQs
Why does uniform cell distribution matter for target validation in bioprinted tissue models?
Uniform cell distribution ensures consistent phenotypic responses across constructs, reducing variability that could obscure target-specific effects during hypothesis testing in discovery workflows.
How does isolating the mixing process as an independent variable improve reproducibility in bioink preparation?
By standardizing the mixing step via a passive mixing unit, variability from manual handling is minimized, enabling reproducible bioink preparation across experiments and users.
What quantitative measurements enable assessment of bioink pre-cellularization success?
Cell viability via trypan blue exclusion and histological markers like glycosaminoglycan and collagen I deposition provide quantitative benchmarks for successful cellularization and construct maturation.
Why are replication requirements critical for cross-functional collaboration in bioprinting R&D?
Replication ensures that bioink pre-cellularization yields consistent results across teams and sites, supporting reliable data sharing and decision-making in multidisciplinary projects.
What statistical analysis capabilities are required to evaluate differences in cell viability between mixing techniques?
Comparative analysis of viability metrics (e.g., day 1 and day 14 survival rates) between passive and manual mixing methods requires appropriate statistical testing to confirm significant improvements.
